文献速递神经肌肉病

基于人群的证据:血清神经丝蛋白作为肌萎缩侧索硬化个体诊断与预后生物标志物

Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis.
PubMed 文献 · Ann Neurol · 2024-08-23

在ALS注册登记Swabia研究的790例ALS患者和570名一般人群对照中,测量血清NfL和pNfH并建立基于人群的Z评分。结果显示两者在人群水平具有高诊断和预后效用,NfL优于pNfH,基于人群的ALS Z评分较绝对原始值显著改善预后效用。

要点

  • 血清NfL在人群水平的诊断和预后效用优于pNfH。
  • 基于人群的ALS Z评分较绝对原始值显著改善预后效用。
  • 解读神经丝蛋白水平需考虑疾病进展速率、ALS表型、BMI和肾功能。

核心结论

  • 基于人群的评估增强了尤其血清NfL作为ALS诊断和预后生物标志物的效用,并促进从受控队列到真实世界人群的转化。

研究设计与样本

  • 在参与流行病学ALS注册登记Swabia研究的790例ALS患者和570名一般人群对照中,测量有可用基线样本的血清NfL和pNfH水平,提供平台特异性(ELLA™)对照参考数据和Z评分,以及ALS中的参考数据、疾病特异性Z评分和纵向数据。

主要发现

  • 神经丝蛋白在人群水平显示出高诊断和预后效用,NfL优于pNfH。
  • 基于人群的ALS Z评分新概念较绝对原始值显著改善预后效用。
  • 两种生物标志物在对照中随年龄增加比在ALS中更强,年龄调整改善了诊断准确性。
  • 疾病进展速率、ALS表型、体重指数(BMI)和肾功能在解读神经丝蛋白水平时需考虑。
  • 纵向神经丝蛋白水平在个体患者中总体稳定,尤其当校正年龄和基线水平后。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Neurofilament light chains (NfL) and phosphorylated neurofilament heavy chains (pNfH), established as diagnostic and prognostic biomarkers in hospital-based amyotrophic lateral sclerosis (ALS) cohorts, are now surrogate markers in clinical trials. This study extends their evaluation to a population level, with the aim of advancing their full establishment and assessing the transferability of biomarker findings from controlled cohorts to real-world ALS populations. METHODS: We measured serum NfL and pNfH levels in all ALS patients (n = 790) and general population controls (n = 570) with available baseline samples participating in the epidemiological ALS Registry Swabia, providing platform-specific (ELLA™) reference data and Z-scores for controls, as well as reference data, disease-specific Z-scores and longitudinal data in ALS. We evaluated the diagnostic and prognostic utility of neurofilaments and quantified the impact of ALS-related factors and non-ALS confounders. RESULTS: Neurofilaments showed high diagnostic and prognostic utility at the population level, with NfL superior to pNfH. The novel concept of a population-based ALS Z-score significantly improved the prognostic utility compared to absolute raw values. Both biomarkers increased more strongly with age in controls than in ALS, and age adjustment improved diagnostic accuracy. Our data show that disease progression rates, ALS phenotype, body mass index (BMI), and renal function need to be considered when interpreting neurofilament levels; longitudinal neurofilament levels were generally stable in individual patients, especially when adjusted for age and baseline levels. INTERPRETATION: Population-based assessment enhances the utility of particularly serum NfL as a diagnostic and prognostic biomarker in ALS and improves the translation of findings from controlled cohorts to real-world populations. ANN NEUROL 2024;96:1040-1057.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Witzel S, Huss A, Nagel G, et al. Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis. Ann Neurol. 2024. PMID: 39177232. doi:10.1002/ana.27054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。